Biopharma dive · 4d ago

Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use

Karyopharm bought an extra month to negotiate with creditors or pursue a deal. Elsewhere, BridgeBio Pharma’s oncology spinout shook up its development plans and a brain-focused gene therapy startup banked $275 million.